Journal article

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

Simone I Richardson, Amy W Chung, Harini Natarajan, Batsirai Mabvakure, Nonhlanhla N Mkhize, Nigel Garrett, Salim Abdool Karim, Penny L Moore, Margaret E Ackerman, Galit Alter, Lynn Morris

PLOS Pathogens | PUBLIC LIBRARY SCIENCE | Published : 2018

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID) R01 grant


Awarded by U.S. Department of Health and Human Services


Awarded by National Research Foundation


Awarded by Bill and Melinda Gates Foundation


Awarded by National Institutes of Health


Funding Acknowledgements

SIR is funded by the National Research foundation (http://www.nrf.ac.za/), the Poliomyelitis Foundation (http://www.prf.ac.za/), the University of the Witwatersrand and was supported by two Collaboration for AIDS Vaccine Scientific Exchange Travel Fellowships from the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/). This study was funded by the South African Medical Research Council Flagship Program (http://www.mrc.ac.za/) and the National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID) R01 grant number: R01AI104387. CAPRISA is funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes for Health (NIH), and U.S. Department of Health and Human Services (grant: AI51794). P.L.M. is supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation (Grant No 98341). M.E.A. is supported by Bill and Melinda Gates Foundation OPP1114729, OPP1146996, National Institutes of Health 1P01AI120756 (NIAID), 1R0AI131975 (NIAID and NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.